Keeping Track: FDA Approves Briviact, Refuses To File Firdapse, Rejects Remune
Executive Summary
The latest drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
Keeping Track: US FDA Approvals Binge Continues With Dupixent, Ocrevus And Zejula; Two CAR-T Are Under Review
The latest drug development news and highlights from our US FDA Performance Tracker.
Keeping Track: Amgen Parsabiv Is Latest To Receive Complete Response; Pfizer Troxyca ER Finally Approved; Remune Returns
The latest drug development news and highlights from our FDA Performance Tracker.
Keeping Track: Gazyva, Afinitor Get New Indications; PTC's Translarna Gets Refuse To File
The latest drug development news and highlights from our FDA Performance Tracker.